🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and tolerability of continuing vorinost...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00907738
Treatments Being Tested
This is a multicentre, open-label, randomised phase II trial comparing azac...
Status
Completed
Location
Barts and the London NHS Trust
Start Date
2012-09
Trial ID
NCT01617226
Treatments Being Tested
Part I evaluates the safety, tolerability and pharmacokinetics (PK) of vori...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00771472
Treatments Being Tested
This study is to evaluate the safety and tolerability of vorinostat in comb...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00479232
Treatments Being Tested
The reason for this study will be to find the safest maximum tolerated dose...
Status
Terminated
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00251589
Treatments Being Tested
The primary purpose of this clinical study is to determine the recommended ...
Status
Completed
Location
Multiple Locations
Start Date
2009-02-13
Trial ID
NCT00858234
Treatments Being Tested
This is a phase I, single-site, study to evaluate the effects of VOR and HI...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2017-06-27
Trial ID
NCT03212989
Treatments Being Tested
The purpose of this investigational study is to determine the safety and to...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00106626
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00875056
Treatments Being Tested
This study is to evaluate the efficacy, safety and tolerability of vorinost...
Status
Terminated
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00486720
Treatments Being Tested